MYnd Analytics, Inc. (39) | Note Agreements (3)
- Form of Convertible Promissory Note of Emmaus Life Sciences, Inc. (included as Exhibit A to Exhibit 10.1) (Filed With SEC on February 16, 2021)
- Promissory Note dated April 24, 2019 (Filed With SEC on January 25, 2021)
- Promissory Note dated May 26, 2019 (Filed With SEC on January 25, 2021)
